ScEpiChem is accepted by Nature Methods!

Tong Zhang joined He lab

Study direction: The effect of epigenetic mutations on the prognosis of leukemia was analyzed by bioinformatics at the single-cell level

Xubin Chen joined He lab

Study direction: Developing novel epigenetic liquid biopsy technologies

Kexin Xian joined He lab

Study direction: Spatial-temporal reconstruction of cellular dynamics and lineage specification during mouse gastrulation using in toto live imaging.

Xiaoxuan Meng joined He lab

Study direction: Epigenomic editing reprograms human totipotent stem cells to hematopoitic cells

Shuaifang Yan joined He lab

Study direction: Long-term live imaging reconstructs in toto cell fate decisions underlying mammalian gastrulation.

Chao Dong joined He lab

Study direction: Developing single-cell multi-omics technologies to analyze drug targets and multimodal epigenomics for clinical drug efficacy evaluation and the study of tumor resistance mechanisms.

Min Liu joined He lab

Study direction: Engineering leukemia stem cells to overcome differentiation blockade in acute myeloid leukemia.

Yaxi Liu joined He lab

Study direction: large-scale single-cell multiomic data engineering and analysis focusing on development and ageing.